Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179714 ↗Kurz gefasst
Scoping Review in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Serban Iancu Papacocea und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Department, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma (GBM) is one of the most aggressive malignant tumors of the brain. We queried PubMed for articles about molecular predictor markers in GBM. This scoping review aims to analyze the most important outcome predictors in patients with GBM and to compare these factors in terms of absolute months of survival benefit and percentages. Performing a gross total resection for patients with GBM undergoing optimal chemo- and radiotherapy provides a significant benefit in overall survival compared to those patients who received a subtotal or partial resection. However, compared to IDH-Wildtype GBMs, patients with IDH-Mutant 1/2 GBMs have an increased survival. MGMT promoter methylation status is another strong outcome predictor for patients with GBM. In the reviewed literature, patients with methylated MGMT promoter lived approximately 50% to 90% longer than those with an unmethylated MGMT gene promoter. Moreover, KPS is an important predictor of survival and quality of life, demonstrating that we should refrain from aggressive surgery in important brain areas. As new therapies (such as TTFs) emerge, we are optimistic that the overall median survival will increase, even for IDH-Wildtype GBMs. In conclusion, molecular profiles are stronger outcome predictors than the extent of neurosurgical resection for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurosurgery Department, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- ENT Department, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- ENT Department, Faculty of Medicine, University of Oradea, 410073 Oradea, Romania.
- Cellular Biology and Histology Department, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
ORCID-Profile: Daniela Vrinceanu, Mihai Dumitru
Zitieren
APA
Papacocea, S. I., Vrinceanu, D., Dumitru, M., Manole, F., Serboiu, C., & Papacocea, M. T. (2024). Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179714
Vancouver
Papacocea SI, Vrinceanu D, Dumitru M, Manole F, Serboiu C, Papacocea MT. Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179714
BibTeX
@article{Papacocea2024,
author = {Papacocea, Serban Iancu and Vrinceanu, Daniela and Dumitru, Mihai and Manole, Felicia and Serboiu, Crenguta and Papacocea, Marius Toma},
title = {Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179714}
}
EUVIMED